Lucid Diagnostics News

Maxim Group Maintains Lucid Diagnostics(LUCD.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsAug 13 15:31 ET

Buy Rating Affirmed for Lucid Diagnostics Amidst Growth and Strategic Advances

TipRanksAug 13 14:39 ET

CCORF Maintains Lucid Diagnostics(LUCD.US) With Buy Rating, Maintains Target Price $3

Moomoo NewsAug 13 07:31 ET

Lucid Diagnostics: Strong Buy Rating on Rising Test Volume and Promising Coverage Prospects

TipRanksAug 13 07:03 ET

Lucid Diagnostics Analyst Ratings

BenzingaAug 13 06:06 ET

Lucid Diagnostics: A Buy Rating Amidst Growing EsoGuard Test Volume and Anticipated Medicare Reimbursement

TipRanksAug 12 14:25 ET

Lucid Diagnostics Analyst Ratings

BenzingaJun 6 13:14 ET

Buy Rating Affirmed for Lucid Diagnostics Amid Positive Financial and Clinical Milestones

TipRanksMay 15 15:05 ET

Lucid Diagnostics Analyst Ratings

BenzingaMay 15 08:26 ET

Lucid Diagnostics (LUCD) Gets a Buy From Cantor Fitzgerald

TipRanksMay 15 07:20 ET

Lucid Diagnostics: A Buy Rating on Operational Growth and Strategic Milestones

TipRanksMay 14 07:41 ET

Analysts Offer Insights on Healthcare Companies: Adicet Bio (ACET), Jasper Therapeutics (JSPR) and Lucid Diagnostics (LUCD)

TipRanksMay 13 11:55 ET

Lucid Diagnostics Analyst Ratings

BenzingaMay 13 11:48 ET

Lucid Diagnostics: Strong Buy Rating With Significant Market Potential Despite Near-Term Losses

TipRanksApr 15 05:21 ET

Lucid Diagnostics Analyst Ratings

BenzingaApr 12 04:38 ET

Buy Rating Affirmed for Lucid Diagnostics Amidst Strong EsoGuard Testing Growth and Clear Reimbursement Path

TipRanksApr 11 16:50 ET

Analysts Are Bullish on Top Healthcare Stocks: Lucid Diagnostics (LUCD), Werewolf Therapeutics (HOWL)

TipRanksApr 10 13:55 ET

Buy Rating Affirmed for PAVmed With Strategic Focus on Lucid Diagnostics and Veris Cancer Care Amid Adjusted Price Target

TipRanksMar 29 07:50 ET

Buy Rating for Lucid Diagnostics: Solid Test Volumes and Strategic Growth Initiatives Propel Market Position

TipRanksMar 28 07:15 ET

Buy Rating Affirmed for Lucid Diagnostics Amid Strong Financials and Strategic Growth Initiatives

TipRanksMar 27 14:50 ET